PRE-CONFERENCE SHORT COURSES | SEPTEMBER 25, 2:00-5:00 PM
SC1: Introduction to GPCR-Based Drug Discovery
Annette Gilchrist, PhD, Professor, Pharmacology, Midwestern University
PRE-CONFERENCE DINNER SHORT COURSES | SEPTEMBER 25, 6:00-8:30 PM
SC7: Enabling Macrocyclic Compounds for Drug Discovery
Mark Peterson, PhD, COO, Cyclenium Pharma, Inc.
SC8: Targeting of Ion Channels with Monoclonal Antibodies
Trevor Wilkinson, PhD, Associate Director, Antibody Discovery and Protein Engineering, Medimmune Ltd., United Kingdom
DINNER SHORT COURSES | SEPTEMBER 27, 7:00-9:30 PM
SC13: GPCR Structure-Based Drug Discovery
Matthew Eddy, PhD, Postdoctoral Fellow, Ray Stevens Laboratory, The Bridge Institute, University of Southern California
Huixian Wu, PhD, Principal Scientist, Structural and Molecular Sciences, Discovery Sciences, Pfizer, Inc. Groton
SC14: Advancing Tools and Technologies for Fragment-Based Design
Daniel A. Erlanson, PhD, Co-Founder, Carmot Therapeutics, Inc.
SC15: Introduction to Targeted Covalent Inhibitors
Mark Schnute, PhD, Associate Research Fellow, Medicine Design, Inflammation & Immunology Research, Pfizer, Inc.
SC16: Immunology Basics
Songqing Na, PhD, Senior Scientist, Biotechnology & Autoimmunity Res-AME, Eli Lilly and Company
Thomas Sundberg, PhD, Senior Research Scientist I, Center for Development of Therapeutics, Broad Institute of MIT and Harvard
SC17: Technologies to Assess Permeability and Efflux in Gram-Negative Bacterial Pathogens
David Six, PhD, Investigator III, Infectious Diseases, Novartis Institutes for BioMedical Research
Ram Iyer, PhD, Principal Scientist (Bacteriology), Entasis Therapeutics, Inc.
* Separate registration required for Short Courses